zorbamycin

 

Topic mentions per year

Topic mentions per year

1971-2016
01219712016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Bleomycin (BLM) is a cancer chemotherapeutic agent that is used in the treatment of several types of tumours. The cytotoxicity of… (More)
Is this relevant?
2017
2017
The bleomycins (BLMs), a family of glycopeptide antibiotics, are currently used clinically in combination with a number of other… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2016
2016
Bleomycin (BLM) is used clinically in combination with a number of other agents for the treatment of several types of tumours… (More)
Is this relevant?
2015
2015
The bleomycins (BLMs), tallysomycins (TLMs), phleomycin, and zorbamycin (ZBM) are members of the BLM family of glycopeptide… (More)
Is this relevant?
2014
2014
The bleomycin (BLM) family of glycopeptide-derived antitumor antibiotics consists of BLMs, tallysomycins (TLMs), phleomycins… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Review
2011
Review
2011
The biosynthetic gene clusters for the glycopeptide antitumor antibiotics bleomycin (BLM), tallysomycin (TLM), and zorbamycin… (More)
  • figure 1
  • figure 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2009
2009
The biosynthetic gene cluster for the glycopeptide-derived antitumor antibiotic zorbamycin (ZBM) was cloned by screening a cosmid… (More)
Is this relevant?
2007
2007
Zorbamycin (1, ZBM) is a glycopeptide antitumor antibiotic first reported in 1971. The partial structures of 1 were speculated on… (More)
Is this relevant?
1971
1971
Zorbamycin (U-30,604E) induces rapid degradation of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in Bacillus subtilis… (More)
Is this relevant?
1971
1971
A genetic recombination system in Streptomyces bikiniensis var. zorbonensis is described. This strain produces a mixture of… (More)
Is this relevant?